Loading clinical trials...
Loading clinical trials...
Usefulness of Gadovist-enhanced FLAIR Imaging in Differentiation Between a Glioblastoma and Solitary Brain Metastasis: Single Center Prospective Study
Conditions
Interventions
Usefulness of Gadovist-enhanced FLAIR imaging in differentiation between a glioblastoma and solitary brain metastasis
Locations
1
South Korea
Korea University Guro Hospital
Seoul, Gurogu, South Korea
Start Date
February 2, 2017
Primary Completion Date
January 25, 2021
Completion Date
January 25, 2021
Last Updated
March 24, 2022
NCT06931652
NCT06759649
NCT07399769
NCT07016490
NCT07043751
NCT05098613
Lead Sponsor
Ryoo, In Seon
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions